Skip to Main Content

Paper Details

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
Blood Adv
1
2023
IGLV3-21R110, IGLV3-21R110 mutation, chronic lymphocytic leukemia, patients
Author NameAffiliation
Catherine J WuThe Broad Institute of MIT and Harvard
Catherine J WuMassachusetts General Hospital
Catherine J WuCenter for Cancer Research, Massachusetts General Hospital
Catherine J WuHarvard Medical School
Gad GetzUniversity Hospital and University of Zurich
Gad GetzUniversity Hospital and University of Zurich
Elias CampoInstitut d'Investigacions Biomediques August Pi i Sunyer
Elias Campo
  • 1 - 8

Datasets

Release 1.2